Aquatic Microfauna Eat Frog-Killing Fungus

Filter-feeders emerge as potential defenders against a deadly amphibian disease.

Written byYao-Hua Law
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Adult female Daphnia magna (left) and D. dentifera (right)ISABELLA OLESKY (COURTESY OF CATHERINE SEARLE)Chytridiomycosis, the deadly disease caused by the fungal pathogen Batrachochytrium dendrobatidis (Bd), has been decimating amphibian populations worldwide since the 1980s. “We have no means to stop its advance,” said Antje Lauer, a microbial ecologist at California State University in Bakersfield, “and no cure that can be used in the wild to protect amphibians from it.”

Bd affects amphibian skin, disrupting its ability to regulate electrolytes in the body, explained Jamie Voyles, an infectious disease ecologist at New Mexico Tech. Infected frogs lose excessive amounts of sodium and potassium, which are critical to keep their hearts pumping. Eventually, their hearts stop.

But new research suggests a potential preventive agent against Bd infection—one that may already be swimming all around the affected amphibians. Two recent studies demonstrated that aquatic microscopic fauna—such as Daphnia, Paramecium, and rotifers—can consume free-floating Bd zoospores, keeping Bd from infecting as many frogs.

Dirk Schmeller, a conservation biologist at the Helmholtz Centre for Environmental Research in Germany, knew that Bd infection rates varied greatly across frog populations in lakes within the Pyrenees mountains, between France and Spain. Curious ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies